Joseph Allegra
Chairman bei VYSTAR CORPORATION
Vermögen: 320 $ am 31.03.2024
Profil
Joseph C.
Allegra is currently the Chairman at Vystar Corp.
He previously worked as a Senior Drug Safety Associate at Genentech, Inc. Dr. Allegra completed his undergraduate degree at Boston University and his graduate and doctorate degrees at the University of Georgia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VYSTAR CORPORATION
0,08% | 31.12.2022 | 10 000 ( 0,08% ) | 320 $ | 31.03.2024 |
Aktive Positionen von Joseph Allegra
| Unternehmen | Position | Beginn |
|---|---|---|
| VYSTAR CORPORATION | Chairman | 14.02.2018 |
Ehemalige bekannte Positionen von Joseph Allegra
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Joseph Allegra
| Boston University | Undergraduate Degree |
| University of Georgia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VYSTAR CORPORATION | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
